In hepatocellular carcinomas, CD44 antisense oligonucleotide significantly down-regulated CD44 expression, induced apoptosis, decreased tumorigenesis and invasion, and increased the cancer cell sensitivity to chemotherapy drugs [114]. This evidence concerns the gene CD44 and hepatocellular carcinoma.